Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 15.15% vs 1.58% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -49.89% vs 18.72% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -80.64% vs -17.37% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 23.75% vs 1.27% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Anhui Fengyuan Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 1.07% vs 15.48% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 15.15% vs 1.58% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -38.46% vs 1.07% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -49.89% vs 18.72% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -82.57% vs -5.86% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -80.64% vs -17.37% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 26.92% vs -6.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 23.75% vs 1.27% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






